InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

26 April 2025

Name:

BIOSIGNAL LIMITED (BOS)
(This company subsequently changed its name to ONE NORTH ENTERTAINMENT LIMITED. You should refer to that name for Status.)

Date of Listing:

28 June 2000

Subsequent Names:

Company Name	Start Date	End Date
ONE NORTH ENTERTAINMENT LIMITED	29/12/2011
RGM MEDIA LIMITED	03/08/2010	29/12/2011

Former Names:

Stock Exchange Status: (updated daily)

This company subsequently changed its name to ONE NORTH ENTERTAINMENT LIMITED. You should refer to that name for Stock Exchange Status.

Legal Status: (updated monthly)

This company subsequently changed its name to ONE NORTH ENTERTAINMENT LIMITED. You should refer to that name for Legal Status.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

This company subsequently changed its name and is now ONE NORTH ENTERTAINMENT LIMITED. You should refer to that name for Capital Gains Tax Status.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

BIOSIGNAL LIMITED(BOS)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

	FROM	TO
RGM MEDIA LIMITED	03/08/2010	29/12/2011
BIOSIGNAL LIMITED	05/04/2004	03/08/2010
CTI COMMUNICATIONS LIMITED		05/04/2004

Shareholder links

Our website ranking of BOS:

(2 out of 5)

COMPANY WEBSITE:

BOS website

BOS email

REGISTRY:

Level 8, 210 George Street, Sydney NSW 2000

Tel : +61 2 9290 9600 or 1300 737 760
Fax : +61 2 9279 0664 or 1300 653 459
RegistryWebsite RegistryEmail

Company details

Address: Suite 145, Level 1 , National Innovation Centre , Australian Technology Park , EVELEIGH , NSW, AUSTRALIA, 1430
Tel: (02) 9209 4126 Fax: (02) 9209 4306

Date first listed: 28/06/2000
Company Secretary:
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Human health research and development

News & Events

Expand this box to read and print

name changed to RGM Media Limited	03/08/2010
the Company advises that ASX has approved an application by the Company for an additional waiver from listing rule 14.7 allowing the Company to issue the shares and options listed below more than 3 months and 1 month (as applicable) after the date of shareholder approval at a General Meeting held on 19 March 2010. The shares and options are as follows: • 70,000,000 fully paid ordinary shares to RGM Entertainment Pte Ltd for the Company's acquisition of RGM Group Pte Ltd; • Up to 30,000,000 fully paid ordinary shares under the Company's prospectus dated 21 April 2010 ("the Prospectus"); and • 200,000 fully paid shares and 200,000 unlisted options to Ayre Nominees Pty Ltd.	29/07/2010
advises that ASX has approved an application by the Company for a waiver from listing rule 14.7 allowing the Company to issue the shares and options listed below more than 3 months and 1 month (as applicable) after the date of shareholder approval at a General Meeting held on 19 March 2010. The shares and options are as follows: • 70,000,000 fully paid ordinary shares to RGM Entertainment Pte Ltd for the Company's acquisition of RGM Group Pte Ltd; • Up to 30,000,000 fully paid ordinary shares under the Company's prospectus dated 21 April 2010; and • 200,000 fully paid shares and 200,000 unlisted options to Ayre Nominees Pty Ltd	25/06/2010
issues a Supplementary Prospectus	18/05/2010
issues a Supplementary Prospectus	04/05/2010
issues a prospectus for the issue of 20 million Shares at an issue price of twenty cents ($0.20) each to raise $4 million, with the ability to accept oversubscriptions for up to an additional 10 million Shares ($2 million) before costs of the Offer	22/04/2010
advises that the 25:1 consolidation of Biosignal's issued capital has been completed	07/04/2010
suspended from quotation immediately, at the request of the Company, pursuant to listing rule 17.3 and paragraph 44 of Guidance Note 12 - Changes to Activities, following shareholder approval for the acquisition of RGM Entertainment Pte Ltd	19/03/2010
securities reinstated	11/02/2010
all resolutions considered at the AGM on 18 December 2009 were carried as ordinary resolutions on a show of hands	08/01/2010
company signs an equity financing agreement	14/12/2009
provides Notice of Annual General Meeting to be held on 18 December	20/11/2009
releases Annual Report	06/11/2009
signals there will be a delay in finalising the annual report	30/09/2009
the company has agreed to buy RGM Group Pte Ltd - the transaction values RGM at $35m	25/09/2009
company advises it has raised $900k by way of a convertible note	21/09/2009
company is making "substantial progess" towards the purchase of assets of RGM Entertainment Pte Ltd	02/09/2009
company releases its Preliminary Final Report	31/08/2009
the company has entered into revised definitive agreements with Commonwealth Biotechnologies Inc (NASDAQ:CBTE) for the sale of the BOS biofilm Intellectual Property	03/08/2009
the securities of Biosignal Limited (the "Company") will be suspended from quotation immediately, at the request of the Company following the Company announcing an agreement with RGM Entertainment Pte Ltd	31/07/2009
name changed from CTI Communications Limited	05/04/2004

name changed to RGM Media Limited	03/08/2010
the Company advises that ASX has approved an application by the Company for an additional waiver from listing rule 14.7 allowing the Company to issue the shares and options listed below more than 3 months and 1 month (as applicable) after the date of shareholder approval at a General Meeting held on 19 March 2010. The shares and options are as follows: • 70,000,000 fully paid ordinary shares to RGM Entertainment Pte Ltd for the Company's acquisition of RGM Group Pte Ltd; • Up to 30,000,000 fully paid ordinary shares under the Company's prospectus dated 21 April 2010 ("the Prospectus"); and • 200,000 fully paid shares and 200,000 unlisted options to Ayre Nominees Pty Ltd.	29/07/2010
advises that ASX has approved an application by the Company for a waiver from listing rule 14.7 allowing the Company to issue the shares and options listed below more than 3 months and 1 month (as applicable) after the date of shareholder approval at a General Meeting held on 19 March 2010. The shares and options are as follows: • 70,000,000 fully paid ordinary shares to RGM Entertainment Pte Ltd for the Company's acquisition of RGM Group Pte Ltd; • Up to 30,000,000 fully paid ordinary shares under the Company's prospectus dated 21 April 2010; and • 200,000 fully paid shares and 200,000 unlisted options to Ayre Nominees Pty Ltd	25/06/2010
issues a Supplementary Prospectus	18/05/2010
issues a Supplementary Prospectus	04/05/2010
issues a prospectus for the issue of 20 million Shares at an issue price of twenty cents ($0.20) each to raise $4 million, with the ability to accept oversubscriptions for up to an additional 10 million Shares ($2 million) before costs of the Offer	22/04/2010
advises that the 25:1 consolidation of Biosignal's issued capital has been completed	07/04/2010
suspended from quotation immediately, at the request of the Company, pursuant to listing rule 17.3 and paragraph 44 of Guidance Note 12 - Changes to Activities, following shareholder approval for the acquisition of RGM Entertainment Pte Ltd	19/03/2010
securities reinstated	11/02/2010
all resolutions considered at the AGM on 18 December 2009 were carried as ordinary resolutions on a show of hands	08/01/2010
company signs an equity financing agreement	14/12/2009
provides Notice of Annual General Meeting to be held on 18 December	20/11/2009
releases Annual Report	06/11/2009
signals there will be a delay in finalising the annual report	30/09/2009
the company has agreed to buy RGM Group Pte Ltd - the transaction values RGM at $35m	25/09/2009
company advises it has raised $900k by way of a convertible note	21/09/2009
company is making "substantial progess" towards the purchase of assets of RGM Entertainment Pte Ltd	02/09/2009
company releases its Preliminary Final Report	31/08/2009
the company has entered into revised definitive agreements with Commonwealth Biotechnologies Inc (NASDAQ:CBTE) for the sale of the BOS biofilm Intellectual Property	03/08/2009
the securities of Biosignal Limited (the "Company") will be suspended from quotation immediately, at the request of the Company following the Company announcing an agreement with RGM Entertainment Pte Ltd	31/07/2009
name changed from CTI Communications Limited	05/04/2004

Your browser may reflect a date of printing in American format.

ASX Announcements (courtesy of ASX)

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Bruce Foy	Non Exec Director
Timothy Boyd	Director
Timothy Morrison	Company Secretary

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.